Xiang Tang Selected Research

Xiang Tang Research Topics

Disease

9	Neoplasms (Cancer) 12/2023 - 01/2021
8	Stroke (Strokes) 02/2023 - 05/2019
4	Inflammation (Inflammations) 01/2024 - 01/2023
4	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 01/2021
2	Overweight 01/2022 - 01/2013
1	Infections 05/2024
1	Pneumonia (Pneumonitis) 05/2024
1	Stomach Neoplasms (Stomach Cancer) 02/2024
1	Body Weight (Weight, Body) 01/2024
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2024
1	Metaplasia 01/2024
1	Weight Gain 12/2023
1	Colorectal Neoplasms (Colorectal Cancer) 04/2023
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2023
1	Dysarthria (Spastic Dysarthria) 01/2023
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2023
1	Breast Neoplasms (Breast Cancer) 09/2022
1	Drug Resistant Epilepsy 07/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022
1	Neoplasm Metastasis (Metastasis) 02/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Deglutition Disorders (Dysphagia) 01/2022
1	Ischemic Stroke 01/2022
1	Diarrhea 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021
1	Atrial Fibrillation 01/2021
1	Weight Loss (Weight Reduction) 01/2020
1	Female Genital Diseases 01/2020
1	Acidosis 11/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Cognitive Dysfunction 01/2018
1	Coma (Comas) 11/2017
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2017
1	Stress Urinary Incontinence 06/2014

Drug/Important Bio-Agent (IBA)

3	Indicators and Reagents (Reagents)IBA 01/2024 - 02/2022
2	LipidsIBA 02/2023 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 01/2022
2	Fibrinogen (Factor I)FDA Link 08/2022 - 01/2022
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2013
1	Exenatide (Byetta)FDA Link 05/2024
1	Tamoxifen FDA LinkGeneric 01/2024
1	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 01/2024
1	spasmolytic polypeptideIBA 01/2024
1	zuojinIBA 01/2024
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 01/2024
1	Capsules (Microcapsules)IBA 01/2024
1	UreaseIBA 01/2024
1	coptisineIBA 10/2023
1	Virulence Factors (Pathogenicity Factors)IBA 10/2023
1	Interleukin-6 (Interleukin 6)IBA 10/2023
1	Interleukin-2 (IL2)IBA 10/2023
1	Particulate MatterIBA 10/2023
1	MucinsIBA 10/2023
1	BerberineIBA 04/2023
1	Histone Deacetylase InhibitorsIBA 01/2023
1	CalciumIBA 01/2023
1	protein kinase C gamma (PRKCG)IBA 01/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2023
1	regorafenibIBA 12/2022
1	MicellesIBA 09/2022
1	Acitretin FDA Link 09/2022
1	Surface-Active Agents (Surfactants)IBA 09/2022
1	Acetate-CoA Ligase (Acetyl CoA Synthetase)IBA 07/2022
1	Cysteine (L-Cysteine)FDA Link 02/2022
1	Cystine (L-Cystine)IBA 02/2022
1	C-Reactive ProteinIBA 01/2022
1	norcantharidinIBA 01/2022
1	EnzymesIBA 01/2022
1	HomocysteineIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	VaccinesIBA 01/2022
1	barium ferriteIBA 11/2021
1	IronIBA 11/2021
1	CarbonIBA 11/2021
1	norpseudopelleterine-N-oxylIBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	Polysaccharides (Glycans)IBA 01/2021
1	3-carboxypropyl-(2-propenyl)nitrosamineIBA 01/2021
1	Serum AlbuminIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020
1	danaparoid (Orgaran)FDA Link 01/2020
1	Acid Sensing Ion ChannelsIBA 11/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	ProcalcitoninIBA 11/2017

Therapy/Procedure

6	Therapeutics 12/2023 - 01/2020
2	Immunotherapy 02/2024 - 12/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024
1	Liver Transplantation 12/2023
1	Radiotherapy 01/2023
1	Ketogenic Diet 07/2022
1	Pancreatectomy 05/2022
1	Vegetarian Diet (Vegetarianism) 01/2022
1	Complementary Therapies (Alternative Medicine) 01/2020
1	Uterine Myomectomy 01/2020
1	Cystectomy 01/2020
1	Transcranial Magnetic Stimulation 05/2019
1	Suburethral Slings (Tension-Free Vaginal Tape) 06/2014
1	Operative Time 06/2014